Aspiriant LLC’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,000
Closed -$44K 282
2022
Q2
$44K Buy
+11,000
New +$44K ﹤0.01% 271